Novan (NOVN) News Today → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free NOVN Stock Alerts Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineStockNews.com Initiates Coverage on Novan (NASDAQ:NOVN)americanbankingnews.com - May 1 at 2:14 AMNovan (NASDAQ:NOVN) Research Coverage Started at StockNews.comamericanbankingnews.com - April 23 at 2:14 AMNovartis AGwsj.com - February 27 at 7:11 PMNovartis AG Registered Sharesmorningstar.com - February 16 at 10:42 PMNovartis AG Registered Shares NOVNmorningstar.com - October 31 at 10:41 PMNovan reaches deals to sell assets in bankruptcy casebizjournals.com - September 8 at 1:15 PMFirm Retention Summary: Novanmsn.com - August 8 at 7:07 AMNovan (NOVN) Price Target Increased by 43.52% to 15.81msn.com - August 3 at 11:15 AMNovan Shares Hit 52-Week Low After Bankruptcy Declarationmarketwatch.com - July 17 at 2:13 PMmarketbeat.com - July 17 at 8:13 AMNovan cuts 50% of its workforce to extend runwaybizjournals.com - June 1 at 12:34 PMNovan drops 13%, will reduce workforce by 50%msn.com - June 1 at 12:34 PMNovan To "Sharpen" Focus, Resources On Berdazimer Gelmarkets.businessinsider.com - May 31 at 9:34 PMNovan Focuses Strategic Direction and Announces Restructuringfinance.yahoo.com - May 31 at 4:33 PMmarketbeat.com - May 31 at 4:05 PMNovan (NASDAQ: NOVN)fool.com - May 21 at 2:48 PMOppenheimer Maintains Novan (NOVN) Outperform Recommendationmsn.com - May 17 at 3:37 AMNOVN: Counting Down to PDUFAfinance.yahoo.com - May 16 at 12:36 PMNovan, Inc.: Novan Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 15 at 9:41 AMNovan earnings: here's what Wall Street expectsmarkets.businessinsider.com - May 15 at 9:41 AMEarnings Preview: Novanmsn.com - May 12 at 4:15 PMNovan Q1 2023 Earnings Previewmsn.com - May 12 at 4:15 PMNovan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhDfinance.yahoo.com - April 20 at 12:14 PMNovan's Return On Capital Employed Overviewmsn.com - April 3 at 8:23 AMNovan to Report Full Year 2022 Financial Results on March 30, 2023finance.yahoo.com - March 23 at 12:23 PMFDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024finance.yahoo.com - March 7 at 8:55 AMJPMorgan names Qian as Southeast Asia equity capital markets chief - Reutersreuters.com - October 19 at 1:22 PMNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® - Yahoo Financefinance.yahoo.com - October 14 at 6:08 PMNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference - GlobeNewswireglobenewswire.com - October 14 at 1:07 PMNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®finance.yahoo.com - October 14 at 1:07 PMGlobal Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028) - Yahoo Financefinance.yahoo.com - October 6 at 7:42 AMWorldwide Acne Treatment Industry to 2027 - Focus on Retinoids, Antibiotics, Hormonal Drugs, Anti-Inflammatory Drugs and Chemical Peels - Yahoo Financefinance.yahoo.com - October 3 at 10:31 AMOutlook on the Acne Treatment Global Market, to 2027 - Rising Public Knowledge of Cosmetic Acne Treatments is Driving Growth - GlobeNewswireglobenewswire.com - September 22 at 9:36 AMEPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA® (calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064% Subgroup Data Analysis at Skin of Color Update 2022 Conference - StreetInsider.comstreetinsider.com - September 15 at 11:07 PMNovan (NASDAQ:NOVN) – Novan Announces That EPI Health, A Novan Company, And MC2 Therapeutics Presented Da - Benzingabenzinga.com - September 15 at 1:06 PMEPI Health, a Novan Company, and MC2 Therapeutics Present - GlobeNewswireglobenewswire.com - September 15 at 8:05 AMNOVN.OQ - Novan Inc | Stock Price & Latest News | Reutersreuters.com - September 5 at 8:56 PMGenital Warts Market Size to Register Subsequent Growth by 2032 as Key Players Such as Verrica Pharmaceuticals, Tamir Biotechnology, Novan Inc., and others are Looking for Opportunities | DelveInsight - Yahoo Financefinance.yahoo.com - August 30 at 6:41 PMNOVN.A - Novan Inc | Stock Price & Latest News | Reutersreuters.com - August 28 at 7:15 PMNOVN: EPI Revenue Trends Are Strong - Benzingabenzinga.com - August 17 at 1:32 PMNovan: Q2 Earnings Snapshot - Greenwich Timegreenwichtime.com - August 13 at 1:14 PMNovan Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Yahoo Financefinance.yahoo.com - August 12 at 12:29 AMPreparing and Aligning Your Biotech Organization for Commercial Success, Upcoming Webinar Hosted by Xtalk - Benzingabenzinga.com - August 11 at 7:20 PMNovan Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireglobenewswire.com - August 11 at 7:20 PMNovan Q2 2022 Earnings Preview (NASDAQ:NOVN) - Seeking Alphaseekingalpha.com - August 10 at 5:38 PMNovan phase 3 trial results published in JAMA amid FDA push - Triangle Business Journal - The Business Journalsbizjournals.com - July 21 at 4:16 PMGlobal Acne Treatment Market, By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027 - Yahoo Financefinance.yahoo.com - July 19 at 1:39 PMNovan stock gains; Oppenheimer begins coverage at Outperform on SB206's market potential - Seeking Alphaseekingalpha.com - July 19 at 1:39 PMNovan Satisfies $16.5 Million Outstanding Promissory Note - GlobeNewswireglobenewswire.com - July 19 at 1:39 PMNovan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology - Yahoo Financefinance.yahoo.com - July 13 at 8:46 PM Get Novan News Delivered to You Automatically Sign up to receive the latest news and ratings for NOVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report NOVN Media Mentions By Week NOVN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NOVN News Sentiment▼0.000.34▲Average Medical News Sentiment NOVN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NOVN Articles This Week▼10▲NOVN Articles Average Week Get Novan News Delivered to You Automatically Sign up to receive the latest news and ratings for NOVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Statera Biopharma News Today Humanigen News Today Bruush Oral Care News Today Context Therapeutics News Today Grifols News Today LAVA Therapeutics News Today Mainz Biomed News Today NLS Pharmaceutics News Today Pharvaris News Today Tiziana Life Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NOVN) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Nvidia. This is the future of AIPorter & CompanyAI “wealth window” is closing June 25thParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novan, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.